Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Equity (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Return on Equity for 11 consecutive years, with 0.64% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 8.0% year-over-year to 0.64%, compared with a TTM value of 0.64% through Dec 2025, down 8.0%, and an annual FY2025 reading of 0.56%, up 22.0% over the prior year.
  • Return on Equity was 0.64% for Q4 2025 at Wave Life Sciences, up from 0.92% in the prior quarter.
  • Across five years, Return on Equity topped out at 134.43% in Q4 2023 and bottomed at 11.57% in Q3 2022.
  • Average Return on Equity over 5 years is 4.72%, with a median of 1.41% recorded in 2024.
  • The sharpest move saw Return on Equity soared 12791bps in 2023, then crashed -13498bps in 2024.
  • Year by year, Return on Equity stood at 3.92% in 2021, then soared by 267bps to 6.52% in 2022, then skyrocketed by 1961bps to 134.43% in 2023, then crashed by -100bps to 0.55% in 2024, then fell by -15bps to 0.64% in 2025.
  • Business Quant data shows Return on Equity for WVE at 0.64% in Q4 2025, 0.92% in Q3 2025, and 0.84% in Q2 2025.